These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23224719)

  • 41. Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial.
    Hou MY; McNicholas C; Creinin MD
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):361-6. PubMed ID: 27419258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The progestogen-only mini-pill.
    Graham S; Fraser IS
    Contraception; 1982 Oct; 26(4):373-88. PubMed ID: 6759029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users.
    Darney PD; Taylor RN; Klaisle C; Bottles K; Zaloudek C
    Contraception; 1996 Feb; 53(2):97-100. PubMed ID: 8838486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of selective oestrogen receptor modulators in the treatment of endometrial bleeding in women using long-acting progestin contraception.
    Grow DR; Reece MT
    Hum Reprod; 2000 Aug; 15 Suppl 3():30-8. PubMed ID: 11041219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding.
    Hickey M; Dwarte D; Fraser IS
    Hum Reprod; 2000 Jul; 15(7):1509-14. PubMed ID: 10875858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
    Gaspard UJ; Deville JL; Dubois M
    Curr Med Res Opin; 1983; 8(6):395-404. PubMed ID: 6406157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
    Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
    Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long acting methods of contraception.
    Newton J
    Br Med Bull; 1993 Jan; 49(1):40-61. PubMed ID: 8324615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.
    Langer RD; Landgren BM; Rymer J; Helmond FA;
    Am J Obstet Gynecol; 2006 Nov; 195(5):1320-7. PubMed ID: 16875644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perivascular smooth muscle alpha-actin is reduced in the endometrium of women with progestin-only contraceptive breakthrough bleeding.
    Rogers PA; Plunkett D; Affandi B
    Hum Reprod; 2000 Aug; 15 Suppl 3():78-84. PubMed ID: 11041224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation between endometrial histology, microvascular density and calibre, matrix metalloproteinase-3 and bleeding pattern in women using a levonorgestrel-releasing intrauterine system.
    Oliveira-Ribeiro M; Petta CA; De Angelo Andrade LA; Bahamondes L; Hidalgo MM
    Hum Reprod; 2004 Aug; 19(8):1778-84. PubMed ID: 15192067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of unscheduled bleeding in women using extended- or continuous-use combined hormonal contraception: a systematic review.
    Godfrey EM; Whiteman MK; Curtis KM
    Contraception; 2013 May; 87(5):567-75. PubMed ID: 23044386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endometrial bleeding.
    ; Collins J; Crosignani PG
    Hum Reprod Update; 2007; 13(5):421-31. PubMed ID: 17337477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of Norplant implants.
    Faúndes A; Alvarez F; Brache V; Cochón L
    Hum Reprod; 1998 Jan; 13(1):188-91. PubMed ID: 9512255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of mechanisms underlying disturbances of bleeding caused by spontaneous dysfunctional uterine bleeding or hormonal contraception.
    Fraser IS; Hickey M; Song JY
    Hum Reprod; 1996 Oct; 11 Suppl 2():165-78. PubMed ID: 8982758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use.
    Belsey EM
    Contraception; 1988 Aug; 38(2):207-25. PubMed ID: 2971506
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Why does menopausal hormone therapy lead to irregular uterine bleeding? Changes to endometrial blood vessels.
    Hickey M; Doherty DA; Fraser IS; Sloboda DM; Salamonsen LA
    Hum Reprod; 2008 Apr; 23(4):912-8. PubMed ID: 18216041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological therapy for abnormal uterine bleeding.
    Pinkerton JV
    Menopause; 2011 Apr; 18(4):453-61. PubMed ID: 21701432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endometrial expression of epithelial neutrophil-activating peptide-78 during the menstrual cycle or in progestin-only contraceptive users with breakthrough bleeding and the influence of doxycycline therapy.
    Chegini N; Luo X; Pan Q; Rhoton-Vlasak A; Archer DF
    Hum Reprod; 2007 Feb; 22(2):427-33. PubMed ID: 17095519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.